Researchers at the University of Massachusetts Amherst have developed a highly sensitive method for DNA detection, which they report improves sensitivity by approximately 100 times, all at no additional cost.

Traditional DNA detection methods often likened to finding a needle in a haystack because many molecules present in a sample can interfere with the result. The newly developed method takes a different approach. It places the test sample within an alternating electric field, allowing the DNA strands to move in a specific oscillation frequency. Researchers can then detect the presence of the target DNA molecule based on its unique movement pattern, even when it's present in very low concentrations.

This development has significant implications for disease detection. Its high sensitivity enables the diagnosis of diseases at much earlier stages, potentially leading to more effective treatments and improved health outcomes.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Moreover, the method's speed is notable. Unlike traditional methods that can take days, weeks, or even months for results, this new approach provides results in minutes due to its all-electric nature. It's suitable for point-of-care testing, eliminating the need for sending samples to labs and waiting for lengthy processing times.

Additionally, the portability of the device makes it ideal for use in resource-limited settings. It's comparable in size to a blood sugar test tool, offering the potential for rapid and accessible diagnostics even in remote areas with limited healthcare infrastructure.

According to Jinglei Ping, the lead author of the study published in PNAS“The nano-mechanoelectrical approach can be also integrated with other bioengineering technologies, like CRISPR, to elucidate nucleic acid signaling pathways, comprehend disease mechanisms, identify novel drug targets and create personalized treatment strategies, including microRNA-targeted therapies.”